Meeting
2015 Gastrointestinal Cancers Symposium
The prognostic factors and the cause of death in patients with advanced or recurrent gastric cancer.
Authors
Sang Woo Lee
Korea University Medical Center, Korea University, Seoul, South Korea
Sang Woo Lee , In Keun Choi , Chang Min Lee , Seung Young Kim , Jong Jin Hyun , Sung Woo Jung , Young Kul Jung , Ja Seol Koo , Jong-Han Kim , Seong-Heum Park , Seung-Joo Kim , Jun Suk Kim
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session A: Cancers of the Esophagus and Stomach
Track
Cancers of the Esophagus and Stomach
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 33, 2015 (suppl 3; abstr 215)
DOI
10.1200/jco.2015.33.3_suppl.215
Abstract #
215
Poster Bd #
E11
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Correlation between postoperative systemic inflammatory response and prognosis in patients with advanced gastric cancer.
First Author: Kenji Kuroda
Poster
2017 Gastrointestinal Cancers Symposium
Prognostic factors of trastuzumab-based chemotherapy in patients with advanced HER2 positive gastric cancer.
First Author: Shoko Marshall
Poster
2013 Gastrointestinal Cancers Symposium
Randomized phase III trial of irinotecan plus cisplatin versus irinotecan alone after S-1 based chemotherapy failure for patients with advanced and recurrent gastric cancer (AGC) (TCOG GI-0801).
First Author: Ken Shimada
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Nivolumab (NIVO) + chemotherapy (chemo) vs chemo as first-line (1L) treatment for advanced gastric cancer/gastroesophageal junction cancer/esophageal adenocarcinoma (GC/GEJC/EAC): 4 year (yr) follow-up of CheckMate 649.
First Author: Kohei Shitara